This company listing is no longer active
Yourgene Health Management
Management criteria checks 2/4
Yourgene Health's CEO is Lyn Rees, appointed in Jul 2018, has a tenure of 5.17 years. total yearly compensation is £394.00K, comprised of 67.5% salary and 32.5% bonuses, including company stock and options. directly owns 2.67% of the company’s shares, worth £439.66K. The average tenure of the management team and the board of directors is 2.8 years and 4.1 years respectively.
Key information
Lyn Rees
Chief executive officer
UK£394.0k
Total compensation
| CEO salary percentage | 67.5% |
| CEO tenure | 5.2yrs |
| CEO ownership | 2.7% |
| Management average tenure | 2.8yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
Yourgene Health Plc (LON:YGEN) Shares Could Be 34% Above Their Intrinsic Value Estimate
Sep 22
Is There An Opportunity With Yourgene Health Plc's (LON:YGEN) 35% Undervaluation?
Apr 15We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Yourgene Health Plc's (LON:YGEN) CEO For Now
Sep 22Estimating The Intrinsic Value Of Yourgene Health Plc (LON:YGEN)
Aug 07Does This Valuation Of Yourgene Health Plc (LON:YGEN) Imply Investors Are Overpaying?
Feb 25What Did Yourgene Health's (LON:YGEN) CEO Take Home Last Year?
Jan 27What Kind Of Shareholders Hold The Majority In Yourgene Health Plc's (LON:YGEN) Shares?
Dec 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -UK£8m |
| Jun 30 2022 | n/a | n/a | -UK£5m |
| Mar 31 2022 | UK£394k | UK£266k | -UK£2m |
| Dec 31 2021 | n/a | n/a | -UK£6m |
| Sep 30 2021 | n/a | n/a | -UK£10m |
| Jun 30 2021 | n/a | n/a | -UK£11m |
| Mar 31 2021 | UK£299k | UK£238k | -UK£12m |
| Dec 31 2020 | n/a | n/a | -UK£8m |
| Sep 30 2020 | n/a | n/a | -UK£4m |
| Jun 30 2020 | n/a | n/a | -UK£3m |
| Mar 31 2020 | UK£220k | UK£190k | -UK£2m |
| Dec 31 2019 | n/a | n/a | UK£1m |
| Sep 30 2019 | n/a | n/a | UK£5m |
| Jun 30 2019 | n/a | n/a | UK£4m |
| Mar 31 2019 | UK£203k | UK£122k | UK£3m |
Compensation vs Market: Lyn's total compensation ($USD490.74K) is above average for companies of similar size in the UK market ($USD349.40K).
Compensation vs Earnings: Lyn's compensation has increased whilst the company is unprofitable.
CEO
Lyn Rees (49 yo)
5.2yrs
Tenure
UK£394,000
Compensation
Mr. Lyn Dafydd Rees serves as Non-Executive Director at MyHealthChecked Plc (formerly known as Concepta PLC) since November 2019. Mr. Rees serves as Chief Executive Officer and Director at Yourgene Health...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.2yrs | UK£394.00k | 2.67% £ 439.7k | |
| Chief Scientific Officer | 2.8yrs | UK£192.00k | 0.22% £ 36.1k | |
| Chief Entrepreneur & Director | 2.8yrs | UK£123.00k | 9.89% £ 1.6m | |
| Interim Chief Financial Officer | less than a year | no data | no data | |
| Vice President of Global Operations | no data | no data | no data | |
| Director of Marketing | 8.5yrs | no data | no data | |
| HR Director | no data | no data | no data |
2.8yrs
Average Tenure
48yo
Average Age
Experienced Management: YGEN's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.2yrs | UK£394.00k | 2.67% £ 439.7k | |
| Chief Entrepreneur & Director | no data | UK£123.00k | 9.89% £ 1.6m | |
| Senior Independent Non-Executive Chairman | 4.2yrs | UK£40.00k | 1.05% £ 173.5k | |
| Non-Executive Director | 1.7yrs | UK£7.00k | no data | |
| Non-Executive Director | 4.1yrs | UK£30.00k | no data | |
| Non-Executive Director | less than a year | no data | no data |
4.1yrs
Average Tenure
56.5yo
Average Age
Experienced Board: YGEN's board of directors are considered experienced (4.1 years average tenure).